| 1 |
33222380 | Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer using the CYP3A Inhibitor Cobicistat. | 2021 Mar |
3 |
| 2 |
31127319 | Clinical implications of an analysis of pharmacokinetics of crizotinib coadministered with dexamethasone in patients with non-small cell lung cancer. | 2019 Jul |
2 |
| 3 |
26180127 | Prediction of Drug-Drug Interactions with Crizotinib as the CYP3A Substrate Using a Physiologically Based Pharmacokinetic Model. | 2015 Oct |
3 |
| 4 |
26381275 | The effects of ketoconazole and rifampin on the single-dose pharmacokinetics of crizotinib in healthy subjects. | 2015 Dec |
7 |
| 5 |
23129213 | Prediction of crizotinib-midazolam interaction using the Simcyp population-based simulator: comparison of CYP3A time-dependent inhibition between human liver microsomes versus hepatocytes. | 2013 Feb |
2 |
| 6 |
23686600 | Crizotinib for the treatment of non-small-cell lung cancer. | 2013 Jun 1 |
2 |